Overview
Michael Telias practices in Tel Aviv, Israel. Mr. Telias is rated as a Distinguished expert by MediFind in the treatment of Fragile X Syndrome. His top areas of expertise are Fragile X Syndrome, Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, and Ganglion Cyst.
His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Fragile X Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Fragile X SyndromeMr. Telias isDistinguished. Learn about Fragile X Syndrome.
- Advanced
- Ganglion CystMr. Telias isAdvanced. Learn about Ganglion Cyst.
- Retinitis PigmentosaMr. Telias isAdvanced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Telias isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Late-Onset Retinal DegenerationMr. Telias isExperienced. Learn about Late-Onset Retinal Degeneration.
- Retinal DetachmentMr. Telias isExperienced. Learn about Retinal Detachment.